{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T13:35:15Z","timestamp":1793885715803,"version":"4.8.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T00:00:00Z","timestamp":1786752000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["UG1HL069254"],"award-info":[{"award-number":["UG1HL069254"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006058","name":"St. Baldrick's Foundation","doi-asserted-by":"publisher","award":["Consortium Grant"],"award-info":[{"award-number":["Consortium Grant"]}],"id":[{"id":"10.13039\/100006058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA181050"],"award-info":[{"award-number":["R01 CA181050"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA040214"],"award-info":[{"award-number":["P30CA040214"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jtct.2026.08.011","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T23:30:17Z","timestamp":1787182217000},"page":"1465.e1-1465.e19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["High Predicted Thiotepa Exposure is Associated with Increased Risk of Thrombotic Microangiopathy and Non-Relapse Mortality in Pediatric Patients Undergoing Alpha-Beta T-Cell Depleted Haploidentical Transplantation"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6146-3952","authenticated-orcid":false,"given":"Christopher C.","family":"Dvorak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1091-2567","authenticated-orcid":false,"given":"Willem","family":"Collier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6160-2791","authenticated-orcid":false,"given":"Soohee","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Holbrook-Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4129-9102","authenticated-orcid":false,"given":"Candelaria","family":"Deimundo Roura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2645-0854","authenticated-orcid":false,"given":"Julie-An","family":"Talano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anant","family":"Vatsayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5651-7426","authenticated-orcid":false,"given":"Nahal","family":"Lalefar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3665-3102","authenticated-orcid":false,"given":"Eric","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine S.","family":"Higham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paibel","family":"Aguayo-Hiraldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neena","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie M.","family":"Waldhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3514-2618","authenticated-orcid":false,"given":"Maryanne C.","family":"Odinakachukwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6119-3270","authenticated-orcid":false,"given":"David A.","family":"Jacobsohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron J.","family":"Keizer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Pulsipher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janel R.","family":"Long-Boyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jtct.2026.08.011_bib0001","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1056\/NEJMsa1311707","article-title":"HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry","volume":"371","author":"Gragert","year":"2014","journal-title":"N Engl J Med"},{"issue":"1-2","key":"10.1016\/j.jtct.2026.08.011_bib0002","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.imlet.2013.09.027","article-title":"Negative depletion of \u03b1\/\u03b2+ T cells and of CD19+ B lymphocytes: a novel frontier to optimize the effect of innate immunity in HLA-mismatched hematopoietic stem cell transplantation","volume":"155","author":"Locatelli","year":"2013","journal-title":"Immunol Lett"},{"issue":"5","key":"10.1016\/j.jtct.2026.08.011_bib0003","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1182\/blood-2014-03-563817","article-title":"HLA-haploidentical stem cell transplantation after removal of \u03b1\u03b2+ T and B cells in children with nonmalignant disorders","volume":"124","author":"Bertaina","year":"2014","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jtct.2026.08.011_bib0004","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1182\/blood-2017-04-779769","article-title":"Outcome of children with acute leukemia given HLA-haploidentical HSCT after \u03b1\u03b2 T-cell and B-cell depletion","volume":"130","author":"Locatelli","year":"2017","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jtct.2026.08.011_bib0005","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.jaci.2017.07.008","article-title":"T-cell receptor \u03b1\u03b2(+) and CD19(+) cell-depleted haploidentical and mismatched hematopoietic stem cell transplantation in primary immune deficiency","volume":"141","author":"Shah","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.jtct.2026.08.011_bib0006","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1182\/blood.2023021336","article-title":"TCR\u03b1\u03b2\/CD19 cell-depleted HLA-haploidentical transplantation to treat pediatric acute leukemia: updated final analysis","volume":"143","author":"Merli","year":"2024","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.jtct.2026.08.011_bib0007","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1182\/blood.2022015959","article-title":"KIR-favorable TCR-\u03b1\u03b2\/CD19-depleted haploidentical HCT in children with ALL\/AML\/MDS: primary analysis of PTCTC ONC1401","volume":"140","author":"Pulsipher","year":"2022","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jtct.2026.08.011_bib0008","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/1097-0142(19830201)51:3<465::AID-CNCR2820510318>3.0.CO;2-9","article-title":"The effect of surgery and chemotherapy on blood NK cell activity in patients with ovarian cancer","volume":"51","author":"Lukomska","year":"1983","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.jtct.2026.08.011_bib0009","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/00007890-199010000-00040","article-title":"Enhancement of T cell-depleted bone marrow allografts in mice by thiotepa","volume":"50","author":"Terenzi","year":"1990","journal-title":"Transplantation"},{"issue":"19","key":"10.1016\/j.jtct.2026.08.011_bib0010","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1200\/JCO.2005.03.3373","article-title":"Isolated CNS relapse of acute lymphoblastic leukemia treated with intensive systemic chemotherapy and delayed CNS radiation: a pediatric oncology group study","volume":"24","author":"Barredo","year":"2006","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.jtct.2026.08.011_bib0011","doi-asserted-by":"crossref","first-page":"e264","DOI":"10.1097\/MPH.0000000000002151","article-title":"Successful bone marrow transplantation with intensive post-transplant intrathecal chemotherapy for CNS relapsed AML in 2 infants","volume":"44","author":"Andolina","year":"2022","journal-title":"J Pediatr Hematol Oncol"},{"issue":"4","key":"10.1016\/j.jtct.2026.08.011_bib0012","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF01834364","article-title":"Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for marrow transplantation: risk factors for early regimen-related toxicity","volume":"68","author":"Przepiorka","year":"1994","journal-title":"Ann Hematol"},{"issue":"3","key":"10.1016\/j.jtct.2026.08.011_bib0013","first-page":"449","article-title":"A phase I-II study of high-dose thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic marrow transplantation","volume":"14","author":"Przepiorka","year":"1994","journal-title":"Bone Marrow Transplant"},{"issue":"17","key":"10.1016\/j.jtct.2026.08.011_bib0014","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM199810223391702","article-title":"Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype","volume":"339","author":"Aversa","year":"1998","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.jtct.2026.08.011_bib0015","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/sj.bmt.1702016","article-title":"Hematopoietic stem cell transplantation for childhood myeloid malignancies after high-dose thiotepa, busulfan and cyclophosphamide","volume":"24","author":"Worth","year":"1999","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.jtct.2026.08.011_bib0016","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ajh.1121","article-title":"Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced myelodysplastic syndrome and acute myelogenous leukemia","volume":"67","author":"Bibawi","year":"2001","journal-title":"Am J Hematol"},{"issue":"15","key":"10.1016\/j.jtct.2026.08.011_bib0017","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1200\/JCO.2005.09.117","article-title":"Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse","volume":"23","author":"Aversa","year":"2005","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.jtct.2026.08.011_bib0018","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/sj.bmt.1702996","article-title":"Megadose transplantation of purified peripheral blood CD34(+) progenitor cells from HLA-mismatched parental donors in children","volume":"27","author":"Handgretinger","year":"2001","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"10.1016\/j.jtct.2026.08.011_bib0019","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.bbmt.2010.05.003","article-title":"Immunohematologic reconstitution in pediatric patients after T cell-depleted HLA-haploidentical stem cell transplantation for thalassemia","volume":"16","author":"Isgr\u00f2","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1016\/j.jtct.2026.08.011_bib0020","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/bmt.2012.186","article-title":"Haploidentical related-donor hematopoietic cell transplantation in children using megadoses of CliniMACs-selected CD34(+) cells and a fixed CD3(+) dose","volume":"48","author":"Dvorak","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.jtct.2026.08.011_bib0021","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/s41409-019-0750-7","article-title":"Improved survival rate in T-cell depleted haploidentical hematopoietic cell transplantation over the last 15 years at a single institution","volume":"55","author":"Mamcarz","year":"2020","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"10.1016\/j.jtct.2026.08.011_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2024.06.020","article-title":"Cyclophosphamide and thiotepa increases risk of transplant-associated thrombotic microangiopathy","volume":"30","author":"Higham","year":"2024","journal-title":"Transplant Cell Ther"},{"issue":"11","key":"10.1016\/j.jtct.2026.08.011_bib0023","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1182\/bloodadvances.2019001242","article-title":"Risk factors for transplant-associated thrombotic microangiopathy and mortality in a pediatric cohort","volume":"4","author":"Schoettler","year":"2020","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.jtct.2026.08.011_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/bloodadvances.2020003455","article-title":"A pragmatic multi-institutional approach to understanding transplant-associated thrombotic microangiopathy after stem cell transplant","volume":"5","author":"Dandoy","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2026.08.011_bib0025","doi-asserted-by":"crossref","DOI":"10.1002\/jcph.70296","article-title":"Prospective evaluation of thiotepa pharmacokinetics in children and young adults undergoing allogeneic or autologous hematopoietic cell transplantation","author":"Brooks","year":"2026","journal-title":"J Clin Pharmacol"},{"issue":"23","key":"10.1016\/j.jtct.2026.08.011_bib0026","doi-asserted-by":"crossref","first-page":"6003","DOI":"10.1182\/bloodadvances.2024012670","article-title":"Effect of rabbit ATG PK on outcomes after TCR-\u03b1\u03b2\/CD19-depleted pediatric haploidentical HCT for hematologic malignancy","volume":"8","author":"Dvorak","year":"2024","journal-title":"Blood Adv"},{"issue":"22","key":"10.1016\/j.jtct.2026.08.011_bib0027","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1182\/blood-2014-12-615757","article-title":"IgH-V(D)J NGS-MRD measurement pre- and early post-allotransplant defines very low- and very high-risk ALL patients","volume":"125","author":"Pulsipher","year":"2015","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.jtct.2026.08.011_bib0028","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27948","article-title":"Molecular assessment of pretransplant chemotherapy in the treatment of juvenile myelomonocytic leukemia","volume":"66","author":"Hecht","year":"2019","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.jtct.2026.08.011_bib0029","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1016\/S2352-3026(17)30029-7","article-title":"Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a multicentre, retrospective, pharmacodynamic cohort analysis","volume":"4","author":"Admiraal","year":"2017","journal-title":"Lancet Haematol"},{"issue":"6","key":"10.1016\/j.jtct.2026.08.011_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2025.03.020","article-title":"High melphalan exposure increases the risk of graft-versus-host disease in pediatric patients undergoing alpha-beta T-cell depleted haploidentical transplantation","volume":"31","author":"Dvorak","year":"2025","journal-title":"Transplant Cell Ther"},{"issue":"10","key":"10.1016\/j.jtct.2026.08.011_bib0031","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.bbmt.2017.06.021","article-title":"Pharmacokinetics and model-based dosing to optimize fludarabine therapy in pediatric hematopoietic cell transplant recipients","volume":"23","author":"Ivaturi","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"14","key":"10.1016\/j.jtct.2026.08.011_bib0032","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1182\/bloodadvances.2018029421","article-title":"Fludarabine exposure in the conditioning prior to allogeneic hematopoietic cell transplantation predicts outcomes","volume":"3","author":"Langenhorst","year":"2019","journal-title":"Blood Adv"},{"issue":"11","key":"10.1016\/j.jtct.2026.08.011_bib0033","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.3390\/pharmaceutics14112462","article-title":"Prospective validation and refinement of a population pharmacokinetic model of fludarabine in children and young adults undergoing hematopoietic cell transplantation","volume":"14","author":"Brooks","year":"2022","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.jtct.2026.08.011_bib0034","doi-asserted-by":"crossref","first-page":"384.e1","DOI":"10.1016\/j.jtct.2025.03.020","article-title":"Fludarabine pharmacokinetic model-based dosing minimizes the risk of graft rejection in pediatric patients undergoing allogeneic hematopoietic cell transplantation","volume":"31","author":"Dvorak","year":"2025","journal-title":"Transplant Cell Ther"},{"issue":"1","key":"10.1016\/j.jtct.2026.08.011_bib0035","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bbmt.2015.09.001","article-title":"International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the mount Sinai acute GVHD international consortium","volume":"22","author":"Harris","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"10.1016\/j.jtct.2026.08.011_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2024.04.006","article-title":"Diagnosing and grading of sinusoidal obstructive syndrome after hematopoietic stem cell transplant of children, adolescent and young adults treated in a pediatric institution with pediatric protocols","volume":"30","author":"Salinas Cisneros","year":"2024","journal-title":"Transplant Cell Ther"},{"issue":"13","key":"10.1016\/j.jtct.2026.08.011_bib0037","first-page":"1049","article-title":"Complement blockade for TA-TMA: lessons learned from a large pediatric cohort treated with eculizumab","volume":"135","author":"Jodele","year":"2020","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jtct.2026.08.011_bib0038","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working Group Report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1016\/j.jtct.2026.08.011_bib0039","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1365-2141.2008.07385.x","article-title":"Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in patients with thalassaemia major","volume":"143","author":"Bernardo","year":"2008","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.jtct.2026.08.011_bib0040","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.bbmt.2012.11.007","article-title":"Treosulfan-thiotepa-fludarabine-based conditioning regimen for allogeneic transplantation in patients with thalassemia major: a single-center experience from north India","volume":"19","author":"Choudhary","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jtct.2026.08.011_bib0041","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1182\/blood-2012-04-423822","article-title":"Allogeneic hematopoietic stem cell transplantation in thalassemia major: results of a reduced-toxicity conditioning regimen based on the use of treosulfan","volume":"120","author":"Bernardo","year":"2012","journal-title":"Blood"},{"issue":"1-2","key":"10.1016\/j.jtct.2026.08.011_bib0042","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF00685643","article-title":"Dosing of thioTEPA for myeloablative therapy","volume":"37","author":"Przepiorka","year":"1995","journal-title":"Cancer Chemother Pharmacol"},{"issue":"3","key":"10.1016\/j.jtct.2026.08.011_bib0043","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/annonc\/mdf052","article-title":"Relationship between exposure and toxicity in high-dose chemotherapy with cyclophosphamide, thiotepa and carboplatin","volume":"13","author":"Huitema","year":"2002","journal-title":"Ann Oncol"},{"issue":"8","key":"10.1016\/j.jtct.2026.08.011_bib0044","doi-asserted-by":"crossref","first-page":"810.e811","DOI":"10.1016\/j.jtct.2024.05.015","article-title":"Model-based antithymocyte globulin in \u03b1\u03b2haplo-hematopoietic stem cell transplantation facilitates engraftment, expedites T cell recovery, and mitigates the risk of acute graft-versus-host disease","volume":"30","author":"Barbarito","year":"2024","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2026.08.011_bib0045","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.692234","article-title":"CYP2B6 functional variability in drug metabolism and exposure across populations\u2014implication for drug safety, dosing, and individualized therapy","volume":"12","author":"Langmia","year":"2021","journal-title":"Front Genetics"},{"key":"10.1016\/j.jtct.2026.08.011_bib0046","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3389\/fgene.2019.00224","article-title":"Polymorphism in cytochrome P450 3A4 is ethnicity related","volume":"10","author":"Guttman","year":"2019","journal-title":"Front Genetics"},{"issue":"6","key":"10.1016\/j.jtct.2026.08.011_bib0047","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nri3212","article-title":"Advances in graft-versus-host disease biology and therapy","volume":"12","author":"Blazar","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jtct.2026.08.011_bib0048","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3389\/fped.2019.00133","article-title":"Transplant-associated thrombotic microangiopathy in pediatric hematopoietic cell transplant recipients: a practical approach to diagnosis and management","volume":"7","author":"Dvorak","year":"2019","journal-title":"Front Pediatr"},{"issue":"12","key":"10.1016\/j.jtct.2026.08.011_bib0049","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1182\/blood.2023022526","article-title":"A prospective multi-institutional study of eculizumab to treat high-risk stem cell transplantation-associated TMA","volume":"143","author":"Jodele","year":"2024","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jtct.2026.08.011_bib0050","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jtct.2022.01.013","article-title":"Association between the magnitude of intravenous busulfan exposure and development of hepatic veno-occlusive disease in children and young adults undergoing myeloablative allogeneic hematopoietic cell transplantation","volume":"28","author":"Bogn\u00e0r","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"11","key":"10.1016\/j.jtct.2026.08.011_bib0051","doi-asserted-by":"crossref","first-page":"e526","DOI":"10.1016\/S2352-3026(16)30114-4","article-title":"Association of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysis","volume":"3","author":"Bartelink","year":"2016","journal-title":"Lancet Haematol"},{"issue":"9","key":"10.1016\/j.jtct.2026.08.011_bib0052","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1182\/blood.V76.9.1867.1867","article-title":"Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens","volume":"76","author":"Clift","year":"1990","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.jtct.2026.08.011_bib0053","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jtct.2025.06.007","article-title":"Conditioning regimens for second allogeneic hematopoietic stem cell transplantation for patients with primary graft failure","volume":"31","author":"Desai","year":"2025","journal-title":"Transplant Cell Ther"},{"issue":"2","key":"10.1016\/j.jtct.2026.08.011_bib0054","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.bbmt.2018.09.016","article-title":"Outcomes after second hematopoietic cell transplantation in children and young adults with relapsed acute leukemia","volume":"25","author":"Lund","year":"2019","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726006172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726006172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T13:18:57Z","timestamp":1793884737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636726006172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":54,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S2666636726006172"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2026.08.011","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High Predicted Thiotepa Exposure is Associated with Increased Risk of Thrombotic Microangiopathy and Non-Relapse Mortality in Pediatric Patients Undergoing Alpha-Beta T-Cell Depleted Haploidentical Transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2026.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society for Transplantation and Cellular Therapy.","name":"copyright","label":"Copyright"}]}}